- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
Globus Medical (GMED)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 461.27 mm | 461.27 mm | 461.27 mm | 461.27 mm | 461.27 mm | 461.27 mm |
Cash burn (monthly) | 107.72 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 301.66 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 159.60 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 1.5 | n/a | n/a | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 497 |
Opened positions | 107 |
Closed positions | 55 |
Increased positions | 166 |
Reduced positions | 149 |
13F shares | Current |
---|---|
Total value | 8.17 tn |
Total shares | 107.91 mm |
Total puts | 129.90 k |
Total calls | 292.30 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 10.86 mm | $898.55 bn |
BlackRock | 10.64 mm | $879.77 bn |
JHG Janus Henderson | 6.61 mm | $547.12 bn |
STT State Street | 3.59 mm | $297.30 bn |
JPM JPMorgan Chase & Co. | 2.80 mm | $231.95 bn |
Burgundy Asset Management | 2.62 mm | $216.54 bn |
Citadel Advisors | 2.57 mm | $212.70 bn |
Wellington Management | 2.50 mm | $206.49 bn |
Sculptor Capital | 2.08 mm | $171.86 bn |
Geode Capital Management | 1.90 mm | $156.97 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 25 | Rhoads Ann D | Class A Common Stock | Sell | Dispose S | No | Yes | 78.68 | 7,500 | 590.10 k | 35,384 |
23 Jan 25 | Zarrilli Stephen T | Stock Option (Right to Buy Class A Common Stock) Class A Common Stock | Grant | Acquire A | No | No | 92.42 | 15,000 | 1.39 mm | 15,000 |
23 Jan 25 | Wolterman Dan | Stock Option (Right to Buy Class A Common Stock) Class A Common Stock | Grant | Acquire A | No | No | 92.42 | 15,000 | 1.39 mm | 15,000 |
23 Jan 25 | Tobin James R | Stock Option (Right to Buy Class A Common Stock) Class A Common Stock | Grant | Acquire A | No | No | 92.42 | 15,000 | 1.39 mm | 15,000 |
23 Jan 25 | Scavilla Daniel T | Stock Option (Right to Buy Class A Common Stock) Class A Common Stock | Grant | Acquire A | No | No | 92.42 | 140,000 | 12.94 mm | 140,000 |